Bates Wells supports the founders of Heart & Lung Imaging Limited (“HLH”), a London-based teleradiology network focused on lung cancer screening, on the sale of the company to RadNet, Inc.

HLH was founded by Professor Sam Hare, Dr Graham Robinson, Dr Jonathan Rodrigues and Dr Aniket Tavare to improve lung cancer outcomes through early detection and accurate diagnosis. HLH’s unique network of over 70 expert cardiothoracic radiologists provides specialist reporting services for the NHS as well as a variety of hospitals and academic institutions.

Through the sale of 75% of their shares to RadNet, Inc. the Founders of HLH present “an offering that can address the challenges of creating a cost-effective population health screening program in the UK and ultimately in the United States and other countries.”

The Bates Wells team was led by Nirav Patel and supported by Sung-Hyui Park, Jasmine Sudworth and Olivia Brooks. The team worked closely with Lindabury, HLH’s US counsel on the matter, throughout the transaction.

Nirav Patel, who heads Bates Wells’ Corporate team, commented:

“HLH’s pioneering work as a leading provider of Targeted Lung Health Checks for the NHS has contributed to the UK National Screening Committee recommending that population-based targeted screening of lung cancer be introduced for high-risk patients across all four nations of the UK. We were really pleased to have been able to support Prof Hare, Dr Robinson, Dr Rodrigues and Dr Tavare in this transaction to help HLH position itself well for the next phase of its screening program.”

Dr Sam Hare, co-founder and Chief Executive Officer of HLH, commented:

• on working with the Bates Wells team:

“It’s been an absolute pleasure to work with the Bates Wells’ team on this transaction. Their attention to detail has been second to none and they have articulated complex concepts in an easy to digest manner. A fantastic legal team all round. Nirav Patel did an excellent job heading up the Bates Wells’ deal team – his calm, clear and measured approach really helped to steer the transaction to a successful conclusion. Thank you.”

• on the transaction:

“We are excited to partner with RadNet in providing a visionary approach to population-based screening that harnesses the power of AI with expert readers to deliver world-class diagnostic accuracy in lung cancer.  RadNet’s experience in both AI and large-scale population health screening will transform the radiologist reporting experience through seamless digital integration of AI with subspecialist chest imaging expertise. By joining the RadNet family, HLH sees an unparalleled opportunity to expand globally to drive improved patient outcomes.”